Raymond James & Associates Has $1.67 Million Position in VanEck Vectors Biotech ETF (NASDAQ:BBH)

Raymond James & Associates decreased its position in VanEck Vectors Biotech ETF (NASDAQ:BBH) by 22.3% during the first quarter, HoldingsChannel reports. The firm owned 12,991 shares of the company’s stock after selling 3,729 shares during the quarter. Raymond James & Associates’ holdings in VanEck Vectors Biotech ETF were worth $1,669,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. First National Bank of South Miami lifted its stake in VanEck Vectors Biotech ETF by 4.8% during the 1st quarter. First National Bank of South Miami now owns 4,298 shares of the company’s stock valued at $552,000 after acquiring an additional 195 shares during the period. Janney Montgomery Scott LLC lifted its stake in VanEck Vectors Biotech ETF by 3.3% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,195 shares of the company’s stock valued at $686,000 after acquiring an additional 200 shares during the period. Segall Bryant & Hamill LLC lifted its stake in VanEck Vectors Biotech ETF by 3.8% during the 4th quarter. Segall Bryant & Hamill LLC now owns 5,440 shares of the company’s stock valued at $602,000 after acquiring an additional 200 shares during the period. Bailard Inc. lifted its stake in VanEck Vectors Biotech ETF by 14.9% during the 4th quarter. Bailard Inc. now owns 2,097 shares of the company’s stock valued at $233,000 after acquiring an additional 272 shares during the period. Finally, Deutsche Bank AG bought a new position in VanEck Vectors Biotech ETF during the 4th quarter valued at about $33,000. Institutional investors own 20.94% of the company’s stock.

BBH opened at $120.18 on Friday. VanEck Vectors Biotech ETF has a 52-week low of $103.25 and a 52-week high of $136.84.

TRADEMARK VIOLATION NOTICE: “Raymond James & Associates Has $1.67 Million Position in VanEck Vectors Biotech ETF (NASDAQ:BBH)” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2019/06/15/raymond-james-associates-has-1-67-million-position-in-vaneck-vectors-biotech-etf-nasdaqbbh.html.

Read More: Understanding Analyst Ratings

Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Vectors Biotech ETF (NASDAQ:BBH).

Institutional Ownership by Quarter for VanEck Vectors Biotech ETF (NASDAQ:BBH)

Receive News & Ratings for VanEck Vectors Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Vectors Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.